Due to a Healthcare Expenditure Scenario, the Tissue Microarray Market Share is Expected to Grow Significantly

 

Tissue Microarray Market Insights:

Market Research Future (MRFR)’s latest study reveals that the global tissue microarray market share is set to expand saliently striking a CAGR of 10.04% during the forecast period 2022 to 2030. Tissue microarray offers cost-benefit and time efficiency compared to the traditional slide-by-slide tissue analysis. It is likely to accelerate its adoption in the healthcare sector over the next couple of years.

Tissue microarray market benefits from the treatment’s potential to study a wide range of tumors at different phases of disease progression. Tissue microarray has developed an application in diagnosis of cancer through basic research, prognostic oncology, and drug discovery. The rising burden of cancer is one of the major factors favoring the expansion of the tissue microarray market.

Tissue microarray is an efficient tool for identification of new diagnostic and prognostic markers. Its extensive application in drug discovery and research & development is one of the major factors projected to drive the tissue microarray market proliferation over the assessment period.

The developments introduced in tissue microarray techniques have simplified the discovery of potential molecular targets for gene-specific therapy which is anticipated to complement the expansion of the market. Nevertheless, its inefficiency for heterogeneous cancer remains an impediment to the market growth.

Market Segmentation:

By procedure, the global tissue microarray market is segmented into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array.

By technology, the tissue microarray market has been segmented into DNA microarray, polymerase chain reaction, next-generation sequencing, northern blotting, and western blotting.

By application, the global tissue microarray market is segmented into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, and comparative genomic hybridization, and sequencing bioinformatics.

By end-user, the tissue microarray market has been segmented into pharmaceutical and biotechnological companies, research organization, and others.

Regional Analysis:

By region, the global tissue microarray market has been segmented into Asia Pacific, Americas, Europe, and the Middle East & Africa. Americas is poised to retain a dominant share of the market towards the end of the forecast period. The growth of the region is attributable to the presence of key players, rising healthcare expenditures, adoption of latest technologies in the healthcare sector, and rising burden of cancer among others.

Europe is estimated to control the second largest share of the market. The developed healthcare of the region coupled with government support for research & development has augmented the tissue microarray market in the region. The trend is likely to perpetuate in the foreseeable future.

Asia Pacific is expected to grow at a relatively higher CAGR during the projection period. The favorable factors of growth of the regional tissue microarray market include the presence of fast-developing economies such as India & China, increasing healthcare expenditure, developing healthcare sector, government’s initiatives to boost medical tourism, etc.

The Middle East & Africa is expected to exhibit sluggish growth. Although the African regions remain laggards, the developments in the healthcare sector of the Middle Eastern countries are set to earn some profits in the forthcoming years.

Competitive Dashboard:

Some of the key players profiled in the Tissue Microarray Market trends report are Illumina, Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, Qiagen, Protein Biotechnologies Inc., Takara Bio, Perkin Elmer, Agilent Technologies, Merck Sharp & Dohme Corp, and General Electric.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

 

Comments

Post a Comment

Popular posts from this blog

The Interventional Cardiology Market Share Will Be Driven by Research Lab Expansion

  Interventional Cardiology Market -Overview The burgeoning number of cases related to heart ailments is estimated to promote the expansion of the interventional cardiology market share . The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. The market is estimated to demonstrate a 8.90% CAGR in the duration of the forecast period. The advancement in healthcare facilities and procedures is estimated to create a promising scope for progress in the interventional cardiology market. The improved funding programs in the global market are predicted to reinforce the interventional cardiology market positively. Segmental Analysis The segmental overview of the interventional cardiology market is carried out on the basis of type, end user, and regions. The type segment of the interventional cardiology market consists of plaque modification devices, coronary guidewires, accessories, stents which further includes bare metal stents, drug-eluti...
Read more

Neurodiagnostics Market Share of Top Key Players 2022-2030 with Industry Growth

  Market Highlights According to MRFR analysis, the Global Neurodiagnostics Market Share is expected to register a CAGR of 7% from 2022 to 2030. Neurodiagnostic tests which are also known as neurodiagnostics. records and monitors electrical activities of patient’s peripheral nerves, spinal cord, and brain. These tests help physicians to confirm or rule out a neurological disorder or other medical condition. The growth of the global neurodiagnostics market is boosted by factors such as rising number of strategic initiatives by key players such as mergers, joint ventures, acquisitions, partnerships, coupled with the advancements in technology across the globe. Furthermore, many non-profit organizations in various countries are working towards creating awareness regarding neurological diseases. However, the high cost of neurodiagnostic treatment is likely to restrain the market growth to a certain extent in the coming years. Market players such as GE Healthcare, Siemens Healthineers,...
Read more

Extracorporeal Membrane Oxygenation Machine Market Share of Top Key Players 2022-2030 with Industry Size & Growth

  Extracorporeal Membrane Oxygenation Machine Market Highlights It is estimated that the global extracorporeal membrane oxygenation machine market share is expected to register a CAGR of 5.1 % during the forecast period of 2022 to 2030. Extracorporeal membrane oxygenation machine is also known as a life support machine. It is used in the treatment of various heart and lung disease. The main function of extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when heart and lung are not functioning properly. This machine is used in the treatment of lung cancer and various other chronic disorders. The extracorporeal membrane oxygenation machine market is driven by various factors such as increasing geriatric population, rising prevalence rates of lung cancer, and other chronic diseases. However, the high cost of surgery and increasing side effect after the treatment is expected to curb the growth of the extracorporeal membrane oxygenation machine market. T...
Read more